- Previous Close
1,035.00 - Open
1,040.00 - Bid 1,010.00 x --
- Ask 1,005.00 x --
- Day's Range
986.00 - 1,040.00 - 52 Week Range
978.00 - 1,415.00 - Volume
591 - Avg. Volume
269 - Market Cap (intraday)
448.27M - Beta (5Y Monthly) 0.86
- PE Ratio (TTM)
16.72 - EPS (TTM)
59.80 - Earnings Date Mar 24, 2025
- Forward Dividend & Yield 20.00 (2.00%)
- Ex-Dividend Date May 13, 2025
- 1y Target Est
1,223.00
Metall Zug AG, through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, rest of Europe, the Americas, the Asia Pacific, and internationally. The company develops, manufactures, and distributes devices and solutions for medical diagnosis, microsurgery, and eye training. It also offers diagnostics equipment, such as slit lamps, perimetry, and biometry for cataract diagnosis and treatment; equipment for ophthalmologists, including stands, chairs, industrial high-precision surgical microscopes, and other accessories; and augmented reality technology and digital imaging for the eye care specialists. In addition, the company supplies dishwashers, thermal equipment, and cleaning agents for catering and hotel sectors. Further, it engages in the management and development of real estate. Metall Zug AG was formerly known as Metallwaren-Holding AG and changed its name to Metall Zug AG in September 2002. Metall Zug AG was founded in 1887 and is headquartered in Zug, Switzerland.
www.metallzug.chRecent News: METN.SW
View MorePerformance Overview: METN.SW
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: METN.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: METN.SW
View MoreValuation Measures
Market Cap
448.27M
Enterprise Value
455.07M
Trailing P/E
16.73
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.02
Price/Book (mrq)
1.04
Enterprise Value/Revenue
1.02
Enterprise Value/EBITDA
5.28
Financial Highlights
Profitability and Income Statement
Profit Margin
18.56%
Return on Assets (ttm)
5.12%
Return on Equity (ttm)
10.50%
Revenue (ttm)
283.42M
Net Income Avi to Common (ttm)
52.59M
Diluted EPS (ttm)
59.80
Balance Sheet and Cash Flow
Total Cash (mrq)
17.25M
Total Debt/Equity (mrq)
17.02%
Levered Free Cash Flow (ttm)
34.77M